(PDF) Serum S100B in Primary Progressive Multiple Sclerosis

Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a

Journal of Negative Results in BioMedicine - United Kingdom

doi 10.1186/1477-5751-3-4

Full Text

Abstract

Available in full text

Categories

Molecular Biology

Date

October 13, 2004

Authors

Siobhan M Leary

Daniel R Altmann

Alan J Thompson

Gavin Giovannoni

Publisher

Springer Nature

Related search

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated With Interferon Beta 1a by 1h-NMR Spectroscopy

Neurotherapeutics

English

T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis

Archives of Neurology

English

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis

English

Fludarabine Add-On Therapy in Interferon-Beta-Treated Patients With Multiple Sclerosis Experiencing Breakthrough Disease

Therapeutic Advances in Neurological Disorders

English

Neutralizing Antibodies in Interferon Beta Treated Patients With Multiple Sclerosis: Knowing What to Do Now

Journal of Neurology

English

Daclizumab Is More Effective in Reducing Relapse Rates in Multiple Sclerosis Patients Than Interferon Beta-1a

Journal of pharmacology & clinical research

English

Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated With Interferon Beta or Glatiramer Acetate

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

English

Interferon-Gamma Activated Calcium Influx in Peripheral Blood Lymphocytes From Patients With Primary and Secondary Progressive Multiple Sclerosis.

Journal of Neurology, Neurosurgery and Psychiatry

English

The Effect of Interferon-Beta on Oxidative Stress in Patients With Multiple Sclerosis

Annals of the College of Medicine, Mosul

English